San Diego

Share Your News

Dicerna Pharmaceuticals: Institutional Buying Heats Up

2/20/18

By JD Henning SA

Dicerna Pharmaceuticals (NASDAQ:DRNA) latest corporate presentation:

117

FO 018 0 reen, Corp Noolnuare4

READ FULL ARTICLE HERE

Posted in Health/Biotech

Stories you Need to Know

David Nevins Interviews Dr. Matthew Frieman, Associate Professor, University of Maryland School of Medicine
Thermo Fisher Scientific Acquires Mesa Biotech
Safest States During COVID-19 – Updated WalletHub Study
2021's States with the Best & Worst Dental Health - WalletHub Study
2021’s Healthiest & Unhealthiest Cities in America – WalletHub Study
Ambu Expands Single-Use Endoscopy Contracts with Two U.S. Group Purchasing Organizations
Leisure Acquisition Corp. Merge With Ensysce Biosciences
Design Therapeutics Secures $125 Million in Series B
States that Have the Fewest COVID-19 Restrictions – Updated WalletHub Study
OncoSec Medical Closes $42.0 Million Public Offering of Common Stock

Contact Our CEO, Edwin Warfield

For partnerships, content marketing or advertising inquiries, please contact Edwin through his LinkedIn Profile

Connect

© Copyright 2026 citybuzz